Skip to main content

UBS Group AG

Position in CTXR — Citius Pharmaceuticals, Inc.

CIK 1610520 ZURICH, V8

Position in CTXR

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$15,931
-$33,591 QoQ
Shares Held
26,335
-52.1% QoQ
Ownership
0.096%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#12
of 43 holders
Holding Since
Jun 2020
22 quarters on record
Voting authority Sole 26% Shared 0% None 74%

Common Shares in CTXR Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,751,270,183 across 562 Biotechnology names. CTXR ranks #431 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in CTXR

Export CSV
22 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $15,931 26,335
2026-03-31 $49,522 55,025
2025-12-31 $59,388 76,436
2025-09-30 $32,131 25,913
2025-06-30 $306,752 192,927
2025-03-31 $100,149 67,215
2024-12-31 $110,268 27,567
2024-09-30 $303 605
2024-06-30 $36,662 62,779
2024-03-31 $120,747 134,613
2023-12-31 $104,096 137,513
2023-09-30 $67,048 98,024
2023-06-30 $85,353 71,128
2023-03-31 $428 366
2022-06-30 $1,041 1,132
2022-03-31 $43,373 24,231
2021-12-31 $150,445 97,692
2021-09-30 $115,226 56,762
2021-06-30 $163,883 47,093
2021-03-31 $201,127 112,993
2020-12-31 $104,225 102,182
2020-06-30 $8,784 7,774